NASDAQ:OFIX - Nasdaq - US68752M1080 - Common Stock - Currency: USD
17.95
-0.15 (-0.83%)
The current stock price of OFIX is 17.95 USD. In the past month the price decreased by -1.81%. In the past year, price increased by 31.5%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,634 full-time employees. The firm operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions specifically related to limb reconstruction and deformity correction unrelated to the spine. Global Orthopedics distributes its products globally through a network of distributors and sales representatives to sell orthopedic products to hospitals and healthcare providers. The company has a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and surgical navigation system. Its products are distributed in 68 countries globally via the Company's sales representatives and distributors.
ORTHOFIX MEDICAL INC
3451 Plano Pkwy
Lewisville TEXAS 75056 US
CEO: Jon Serbousek
Employees: 1634
Company Website: https://ir.orthofix.com/ir-home/default.aspx
Investor Relations: https://ir.orthofix.com
Phone: 12149372000
The current stock price of OFIX is 17.95 USD. The price decreased by -0.83% in the last trading session.
The exchange symbol of ORTHOFIX MEDICAL INC is OFIX and it is listed on the Nasdaq exchange.
OFIX stock is listed on the Nasdaq exchange.
12 analysts have analysed OFIX and the average price target is 24.79 USD. This implies a price increase of 38.08% is expected in the next year compared to the current price of 17.95. Check the ORTHOFIX MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ORTHOFIX MEDICAL INC (OFIX) has a market capitalization of 685.87M USD. This makes OFIX a Small Cap stock.
ORTHOFIX MEDICAL INC (OFIX) currently has 1634 employees.
ORTHOFIX MEDICAL INC (OFIX) has a support level at 17.94 and a resistance level at 18. Check the full technical report for a detailed analysis of OFIX support and resistance levels.
The Revenue of ORTHOFIX MEDICAL INC (OFIX) is expected to grow by 7.41% in the next year. Check the estimates tab for more information on the OFIX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
OFIX does not pay a dividend.
ORTHOFIX MEDICAL INC (OFIX) will report earnings on 2025-02-25, before the market open.
The PE ratio for ORTHOFIX MEDICAL INC (OFIX) is 1795. This is based on the reported non-GAAP earnings per share of 0.01 and the current share price of 17.95 USD. Check the full fundamental report for a full analysis of the valuation metrics for OFIX.
The outstanding short interest for ORTHOFIX MEDICAL INC (OFIX) is 1.85% of its float. Check the ownership tab for more information on the OFIX short interest.
ChartMill assigns a technical rating of 7 / 10 to OFIX. When comparing the yearly performance of all stocks, OFIX is one of the better performing stocks in the market, outperforming 80.58% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to OFIX. Both the profitability and financial health of OFIX have multiple concerns.
Over the last trailing twelve months OFIX reported a non-GAAP Earnings per Share(EPS) of 0.01. The EPS decreased by -94.44% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -13.71% | ||
ROE | -22.63% | ||
Debt/Equity | 0.25 |
ChartMill assigns a Buy % Consensus number of 82% to OFIX. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of -1324% and a revenue growth 7.41% for OFIX